https://www.selleckchem.com/pr....oducts/ro5126766-ch5
Patients' motivations for undergoing direct-acting antiviral (DAA) therapy for chronic hepatitis C may include anticipation of treatment benefits not well described in the literature. Evaluate patients' anticipated and actualized improvements in several domains of functioning before and after viral cure. Pre-post-study utilizing in-depth interviews with 28 patients prior to, and several months after, DAA therapy. Interviews were audio-recorded, transcribed, coded, and analyzed by two qualitative experts. Patients had a media
Like
Comment
Share
